18 studies found for:    " March 07, 2012":" April 06, 2012"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
RSS Create an RSS feed from your search for:
" March 07, 2012":" April 06, 2012"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Safety and Efficacy of Darunavir/Cobicistat/Emtricitabine/GS-7340 Single Tablet Regimen Versus Cobicistat-boosted Darunavir Plus Emtricitabine/Tenofovir Disoproxil Fumarate Fixed Dose Combination in HIV-1 Infected, Antiretroviral Treatment Naive Adults
Conditions: Acquired Immunodeficiency Syndrome;   HIV Infections
Interventions: Drug: D/C/F/TAF;   Drug: DRV;   Drug: COBI;   Drug: FTC/TDF;   Drug: Placebo to match D/C/F/TAF;   Drug: Placebo to match DRV;   Drug: Placebo to match COBI;   Drug: Placebo to match FTC/TDF
2 Active, not recruiting Diagnosis and Treatment of Co-infection With Human Immunodeficiency Virus /Latent Tuberculosis Infection (HIV/TBL)
Conditions: Human Immunodeficiency Virus (HIV);   Tuberculosis (TB);   Latent Tuberculosis Infection (LTI)
Intervention: Drug: Isoniazid
3 Recruiting Study Comparing Two Alternatives of Antiretroviral Therapy as Post-exposure Prophylaxis to HIV-1: Tenofovir + Emtricitabine + Lopinavir/Ritonavir Versus Tenofovir + Emtricitabine + Raltegravir (RAL-PEP)
Condition: HIV Infection
Interventions: Drug: Tenofovir, Emtricitabine, Lopinavir/r;   Drug: Tenofovir, Emtricitabine, Raltegravir
4 Active, not recruiting
Has Results
Study Assessing Dolutegravir in HIV-1 Infected Subjects With Virus Resistant to Raltegravir and/or Elivitegravir
Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: dolutegravir 50 mg twice daily;   Drug: dolutegravir placebo twice daily;   Drug: Open-label dolutegravir 50mg twice daily
5 Completed A Study to Evaluate the Effect of Boceprevir and Telaprevir on Dolutegravir Pharmacokinetics in Healthy Adult Subjects (ING115697).
Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: DTG;   Drug: BCV;   Drug: TVR
6 Active, not recruiting Evaluating the Safety and Immune Response of a Prime-Boost HIV Vaccine Regimen in Healthy, HIV-Uninfected, Vaccinia-Naive Adults
Condition: HIV Infections
Interventions: Biological: GEO-D03 DNA vaccine;   Biological: MVA/HIV62B (MVA62B) vaccine;   Biological: Placebo for GEO-D03 DNA;   Biological: Placebo for MVA62B:
7 Recruiting Project RETAIN: Providing Integrated Care for HIV-Infected Crack Cocaine Users
Conditions: HIV;   AIDS;   Substance Abuse
Intervention: Behavioral: Retention Clinic
8 Recruiting Intervention to Improve Engagement in Care Among Newly Diagnosed HIV-positive Men
Conditions: HIV;   Patient Compliance
Interventions: Behavioral: Positive Choices;   Behavioral: Personalized Cognitive Counseling
9 Recruiting A Double-Blind, Placebo Controlled Study of Intravenous Immunoglobulin for HIV-Associated Myelopathy
Condition: HIV-associated Myelopathy
Interventions: Drug: Intravenous Immunoglobulin;   Drug: Placebo
10 Recruiting Sitagliptin and HIV
Conditions: Inflammation;   Macrophage Infiltration;   Cardiovascular Disease
Interventions: Drug: Sitagliptin;   Drug: Placebo
11 Completed Positively Smoke Free on the Web (PSFW) for Smokers Living With HIV
Conditions: Tobacco Use Cessation;   Tobacco Cessation;   Tobacco Use Disorder;   Tobacco Dependence;   Tobacco-Use Disorder;   Virus, Human Immunodeficiency
Interventions: Behavioral: Web-Based Tailored Smoking Cessation Intervention;   Behavioral: Standard of Care
12 Completed
Has Results
The Rilpivirine Cerebrospinal-fluid (CSF) Study
Condition: HIV
Intervention: Drug: Rilpivirine
13 Completed
Has Results
Part A: Drug Interaction Study of Sofosbuvir and Antiretroviral Therapy (ART) Combinations in HIV and Hepatitis C Virus (HCV) Co-infected Patients. Part B: Efficacy and Safety of Sofosbuvir for 12 Weeks in HIV/HCV Co-infected Patients.
Conditions: Hepatitis C;   HIV
Interventions: Drug: SOF;   Drug: EFV/FTC/TDF;   Drug: EFV;   Drug: ZDV/3TC;   Drug: ATV;   Drug: Ritonavir;   Drug: FTC/TDF;   Drug: DRV;   Drug: RAL;   Drug: PEG;   Drug: RBV
14 Unknown  Reducing Drug Use and HIV Risk in Drug-dependent Adults Arrested for Prostitution
Conditions: Substance-related Disorders;   HIV Risk Behavior
Interventions: Behavioral: Therapeutic Workplace;   Drug: Methadone;   Drug: Buprenorphine
15 Recruiting Prediction and Pathogenesis of the Immune Reconstitution Inflammatory Syndrome
Conditions: Immune Reconstitution Inflammatory Syndrome;   Opportunistic Infections
Intervention:
16 Terminated Safety Study of Fluconazole in Combination With Flucytosine for the Treatment of Early Cryptococcal Infection
Condition: Cryptococcal Infection Disseminated
Interventions: Drug: Flucytosine and fluconazole;   Drug: Fluconazole
17 Suspended Collecting and Studying Tissue Samples From Patients With HIV-Associated Malignancies
Conditions: Anal Cancer;   Cervical Cancer;   Lung Cancer;   Lymphoma;   Nonneoplastic Condition
Interventions: Genetic: DNA analysis;   Genetic: RNA analysis;   Genetic: gene expression analysis;   Genetic: polymorphism analysis;   Other: biologic sample preservation procedure;   Other: flow cytometry;   Other: laboratory biomarker analysis;   Other: medical chart review
18 Recruiting HIV Prevention Intervention for Young Transgender Women
Condition: Sexual Transmission of Infection
Interventions: Behavioral: HIV prevention intervention;   Behavioral: Diet and Nutrition

Indicates status has not been verified in more than two years